Highlights from the 5th Annual International Congress on Monoclonal Antibodies in Cancer Quebec City, Canada, August 2005; 5th International Prostate Cancer Congress, Rio Grande, Puerto Rico, July 2005; 41st Annual Meeting of the American Society of Clinical Oncology, Orlando, Florida, May 2005.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D019496:Cancer Vaccines; D051152:Clusterin / Q000378:metabolism; D006801:Humans; D008297:Male; D008565:Membrane Proteins / Q000276:immunology; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D017430:Prostate-Specific Antigen / Q000276:immunology*; D011471:Prostatic Neoplasms / Q000378:metabolism / Q000628:therapy*; D013873:Thionucleotides / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D019496:Cancer Vaccines; D051152:Clusterin; D008565:Membrane Proteins; C503781:OGX-011; D016376:Oligonucleotides, Antisense; D013873:Thionucleotides; C084839:thymic shared antigen-1; D017430:Prostate-Specific Antigen